StockData
FibroBiologics, Inc. logo

FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.90−0.02 (-2.56%)

Close on Nov 16, 2026Market cap $6.02MP/E –Yield –

FibroBiologics cash

Cash and short-term investments held at the end of each period.

FibroBiologics's cash was $3.52M at Jun 30, 2026. For fiscal 2025 it was $4.89M, down 65.0% from the year before. The highest annual figure on record is $13.99M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.89M-65.0%
FY2024Dec 31, 2024$13.99M+52.6%
FY2023Dec 31, 2023$9.16M+304.4%
FY2022Dec 31, 2022$2.27M+456.8%
FY2021Dec 31, 2021$407.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.52M-60.3%
Q1 FY2026Mar 31, 2026$1.48M-82.9%
Q4 FY2025Dec 31, 2025$4.89M-65.0%
Q3 FY2025Sep 30, 2025$4.87M-37.8%
Q2 FY2025Jun 30, 2025$8.85M+48.1%
Q1 FY2025Mar 31, 2025$8.67M+6.2%
Q4 FY2024Dec 31, 2024$13.99M+52.6%
Q3 FY2024Sep 30, 2024$7.83M-27.3%
Q2 FY2024Jun 30, 2024$5.97M-47.5%
Q1 FY2024Mar 31, 2024$8.16M-44.7%
Q4 FY2023Dec 31, 2023$9.16M+304.4%
Q3 FY2023Sep 30, 2023$10.77M+2545.2%
Q2 FY2023Jun 30, 2023$11.38M–
Q1 FY2023Mar 31, 2023$14.74M–
Q4 FY2022Dec 31, 2022$2.27M–
Q4 FY2021Dec 31, 2021$407.00K–

More FibroBiologics figures

See a number that looks wrong?